Sai Parenterals Ltd Dividend

Sai Parenterals Ltd Dividend - Payout, Yield & Future Updates

Image

Sai Parenterals Ltd

NSE: SAIPARENT

Dividend Payout (-)

-

Ex-Dividend Date: NA

null Dividend - History

  • The Latest Trading Price of Sai Parenterals Ltd is ₹ 406.4 as of 02 Apr 16:01.

swot
swot

Monitoring Sai Parenterals Ltd share price can help you stay informed about potential market shifts and opportunities.

Dividend Payout Over Time

No data available

Overview of Dividend

  • <h2><strong>Types of Dividend</strong></h2><br> <h3>Special Dividend</h3> <p>A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.</p> <br> <h3>Preferred Dividend</h3> <p>A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.</p> <br> <h3>Interim Dividend</h3> <p>Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.</p> <br> <h3>Final Dividend</h3> <p>A final dividend is issued after the year's accounts have been compiled.
  • Aside from this, the following list highlights the most prevalent sorts of dividends:</p> <br>.

Types of Dividend


Special Dividend

A dividend is paid on common stock when a company has accumulated substantial profits over years, often seen as excess cash that doesn't need immediate use.


Preferred Dividend

A quarterly dividend is paid to preferred stock owners, typically accumulating a fixed amount, and is earned on shares that function more like bonds.


Interim Dividend

Companies declare interim dividends before final full-year accounts are prepared, specifically in India, during the financial year from April to March of the following year.


Final Dividend

A final dividend is issued after the year's accounts have been compiled. Aside from this, the following list highlights the most prevalent sorts of dividends:


Dividend Yield Comparison With Top Peers

* All values are in %

Image

Sai Parenterals Ltd

NSE: SAIPARENT

Share Price

₹ 406.4

14.40 (3.67%)

stock direction

Last updated on: Apr 02, 2026

Company Fundamentals for Sai Parenterals Ltd

Dividend Payout Over Time

No data available

Net Profit Vs Dividend Per Share

SWOT Analysis

Strength

0

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Sai Parenterals Ltd

Historical Market Cap of Sai Parenterals Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Sai Parenterals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Sai Parenterals Ltd News Hub

Sai Parenteral's IPO subscribed 41%

The initial public offer (IPO) of Sai Parenteral's received bids for 30,82,788 shares as against 75,

Read more

25 Mar 26

Sai Parenteral's IPO subscribed 1.01 times

The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,

Read more

27 Mar 26

Sai Parenteral's IPO ends with 1.05 times subscription

The initial public offer (IPO) of Sai Parenteral's received bids for 78,80,972 shares as against 75,

Read more

30 Mar 26

Sai Parenterals IPO lists today in B group

The equity shares of Sai Parenterals (Scrip Code: 544742) are listed effective 02 April 2026 and adm

Read more

02 Apr 26

About Sai Parenterals Ltd

  • Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad.
  • Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022. Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets.
  • Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions